Continuous molecular remission and regression of side effects after discontinuation of salvage therapy with sorafenib and donor lymphocyte infusions in a young patient with relapsed AML

MeSH terms

• Alopecia / chemically induced
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects*
• Child, Preschool
• Female
• Humans
• Leukemia, Myeloid, Acute / diagnosis
• Leukemia, Myeloid, Acute / therapy*
• Lymphocyte Transfusion* / methods
• Neoplasm Recurrence, Local / diagnosis
• Neoplasm Recurrence, Local / therapy*
• Niacinamide / administration & dosage
• Niacinamide / adverse effects
• Niacinamide / analogs & derivatives*
• Phenylurea Compounds / administration & dosage
• Phenylurea Compounds / adverse effects*
• Salvage Therapy* / methods
• Sorafenib
• Tissue Donors